Christoph H Westphal - Net Worth and Insider Trading
Christoph H Westphal Net Worth
The estimated net worth of Christoph H Westphal is at least $30 Million dollars as of 2024-04-26. Christoph H Westphal is the 10% Owner of TScan Therapeutics Inc and owns about 2,315,423 shares of TScan Therapeutics Inc (TCRX) stock worth over $17 Million. Christoph H Westphal is the Executive Chairman of Verastem Inc and owns about 956,310 shares of Verastem Inc (VSTM) stock worth over $9 Million. Christoph H Westphal is also the Director of Momenta Pharmaceuticals Inc and owns about 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $4 Million. Besides these, Christoph H Westphal also holds Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) . Details can be seen in Christoph H Westphal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christoph H Westphal has not made any transactions after 2021-07-20 and currently still holds the listed stock(s).
Transaction Summary of Christoph H Westphal
Christoph H Westphal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christoph H Westphal owns 7 companies in total, including Salarius Pharmaceuticals Inc () , Verastem Inc () , and Millendo Therapeutics Inc () among others .
Click here to see the complete history of Christoph H Westphal’s form 4 insider trades.
Insider Ownership Summary of Christoph H Westphal
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Salarius Pharmaceuticals Inc | 2018-10-16 | 10 percent owner | |
Verastem Inc | 2014-12-19 | director & 10 percent owner & President & Chief Exec Officer | |
Millendo Therapeutics Inc | 2014-03-07 | director & 10 percent owner | |
Momenta Pharmaceuticals Inc | 2005-05-26 | director | |
Alnylam Pharmaceuticals Inc | 2004-05-27 | director & 10 percent owner | |
Tempest Therapeutics Inc | 2013-06-07 | director & 10 percent owner | |
TScan Therapeutics Inc | 2021-07-20 | director & 10 percent owner |
Christoph H Westphal Latest Holdings Summary
Christoph H Westphal currently owns a total of 5 stocks. Among these stocks, Christoph H Westphal owns 2,315,423 shares of TScan Therapeutics Inc (TCRX) as of July 20, 2021, with a value of $17 Million and a weighting of 56.76%. Christoph H Westphal owns 956,310 shares of Verastem Inc (VSTM) as of December 19, 2014, with a value of $9 Million and a weighting of 29.63%. Christoph H Westphal also owns 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 25, 2004, with a value of $4 Million and a weighting of 13.53%. The other 2 stocks Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) have a combined weighting of 0.08% among all his current holdings.
Latest Holdings of Christoph H Westphal
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TCRX | TScan Therapeutics Inc | 2021-07-20 | 2,315,423 | 7.29 | 16,879,434 |
VSTM | Verastem Inc | 2014-12-19 | 956,310 | 9.22 | 8,812,397 |
MNTA | Momenta Pharmaceuticals Inc | 2004-06-25 | 76,648 | 52.48 | 4,022,487 |
MLND | Millendo Therapeutics Inc | 2014-03-07 | 20,122 | 1.06 | 21,329 |
SLRX | Salarius Pharmaceuticals Inc | 2018-10-16 | 6,306 | 0.50 | 3,147 |
Holding Weightings of Christoph H Westphal
Christoph H Westphal Form 4 Trading Tracker
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 133,333 shares on July 20, 2021, which cost Christoph H Westphal around $2 Million.
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 1,500 shares on December 19, 2014, which cost Christoph H Westphal around $12,750.
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 160,000 shares on June 25, 2004, which cost Christoph H Westphal around $1 Million.
More details on Christoph H Westphal's insider transactions can be found in the Insider Trading History of Christoph H Westphal table.Insider Trading History of Christoph H Westphal
- 1
Christoph H Westphal Trading Performance
GuruFocus tracks the stock performance after each of Christoph H Westphal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christoph H Westphal is -6.98%. GuruFocus also compares Christoph H Westphal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christoph H Westphal within 3 months outperforms 19 times out of 76 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christoph H Westphal's insider trading performs compared to the benchmark.
Performance of Christoph H Westphal
Average Return
-30.89%
Outperforming Transactions
13%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -0.56 | -6.98 | -19.96 | -30.89 | -41 | -56.53 |
Relative Return to S&P 500(%) | -0.98 | -7.73 | -22.85 | -40.66 | -52.53 | -66.87 |
Christoph H Westphal Ownership Network
Ownership Network List of Christoph H Westphal
Ownership Network Relation of Christoph H Westphal
Christoph H Westphal Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Christoph H Westphal is the 10 percent owner of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Christoph H Westphal Mailing Address
Above is the net worth, insider trading, and ownership report for Christoph H Westphal. You might contact Christoph H Westphal via mailing address: C/o Alnylam Pharmaceuticals, Inc, 300 Third Street, Cambridge Ma 02142.